Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

0.6601
Delayed Data
As of 11:32am ET
 -0.0099 / -1.48%
Today’s Change
0.54
Today|||52-Week Range
1.23
+22.24%
Year-to-Date
No recent news for Aveo Pharmaceuticals Inc.

Today’s Trading

Previous close0.67
Today’s open0.65
Day’s range0.63 - 0.66
Volume70,051
Average volume (3 months)270,189
Market cap$50.8M
Dividend yield--
Data as of 11:32am ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+73.27%
Earnings growth (this year)-59.26%
Earnings growth (next 5 years)--
Revenue growth (last year)+4.97%
P/E ratioNM
Price/Sales3.69
Price/Book2.26

Competitors

 Today’s
change
Today’s
% change
MTEXMannatech Inc-0.19-0.98%
GLMDGalmed Pharmaceutica...-0.11-2.71%
EBIOEleven Biotherapeuti...-0.03-1.54%
AVIRAviragen Therapeutic...+0.01+0.78%
Data as of 11:30am ET, 01/20/2017

Financials

Next reporting dateMarch 21, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$19.0M
Annual profit (last year)-$15.0M
Net profit margin-78.85%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael P. Bailey
Chief Financial Officer
Keith S. Ehrlich
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs